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1. Introduction
   Among the 34 fundamental phyla of life, 17 have been 
reported on land while 32 of them are found in the sea (with 
some overlaps) and among these, the marine organisms 
represent a majorly unexplored domain, having highest 
PEER REVIEW                            ABSTRACT
KEYWORDS
Marine invertebrate, Mollusca, Antiangiogenic, CAM, Cautery, Retinopathy 
Objective: To evaluate the antiangiogenic potential of twenty two marine invertebrate species of 
Phylum Mollusca from south east coast of India. 
Methods: Live specimens of molluscan species were collected and their methanolic extracts 
were evaluated for preliminary antiangiogenic activity using the in ovo chick chorio-allantoic 
membrane assay. The extracts were further evaluated for in vivo antiangiogenic activity using 
chemical cautery induced corneal neovascularization assay in rats and oxygen induced 
retinopathy assay in rat pups. 
Results: In the chick chorio-allantoic membrane assay, four methanolic extracts of marine 
molluscan species viz. Meretrix meretrix, Meretrix casta, Telescopium telescopium and Bursa 
crumena methanolic extracts exhibited noticeable antiangiogenic activity at the tested 
concentration of 200 µg whereby they significantly inhibited the VEGF induced proliferation of 
new blood vessels. Among these four extracts, the methanolic extract of Meretrix casta exhibited 
relatively higher degree of antiangiogenic activity with an inhibitiory percentage (64.63%) 
of the VEGF induced neovascularization followed by the methanolic extracts of Telescopium 
telescopium (62.02%), Bursa crumena (60.48%) and Meretrix meretrix (47.01%). These four methanolic 
extracts were further evaluated for in vivo antiangiogenic activity whereby the methanolic 
extract of Telescopium telescopium exhibited most noticeable inhibition (42.58%) of the corneal 
neovascularization in rats in comparison to the sham treated group, and also exhibited most 
noticeable inhibition (31.31%) of the oxygen induced retinal neovascularization in rat pups in 
comparison to the hyperoxia group that was observed for considerable retinal neovascularization. 
Conclusions: The significant antiangiogenic activity evinced by the extract of Telescopium 
telescopium merits further investigation for ocular neovascular diseases. 
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chances for the identification of compounds with higher 
potency and novel biological activities[1]. This has been 
shown in the recent past as much attention has been given 
to the approach of isolating novel chemical structures and 
compounds from marine natural products (MNPs) whereby 
MNPs bioprospecting has yielded a considerable number of 
drug candidates with potent anticancer properties with some 
of these possessing novel mechanisms of action[2]. Other 
than anticancer agents, many therapeutically successful 
drugs like lipid lowering agents, immuno-suppressants, 
antifungals, antivirals, anti-inflammatory, analgesic, anti-
malarial, anti-HIV, etc. have been obtained from marine 
sources. 
   Marine invertebrates constitute one of the major groups 
of marine organisms from which a wide range of medicinal 
benefits have been devised in addition to the large numbers 
of MNPs that have been discovered till date[3]. Seafood diet 
from edible marine invertebrates such as molluscs has been 
linked with various medicinal benefits to improve human 
health[4]. Throughout history, molluscs have provided a 
wide range of human resources, including food, shells, dyes 
and medicines. In many cultures, shelled gastropods and 
bivalves are regarded as a delicacy or healthy food and they 
also feature in a range of traditional natural remedies[5]. 
In most cases, there has been no scientific research 
undertaken to substantiate the health benefits of molluscs. 
However, there is increasing interest in the bioactivity of 
mollusc extracts and secondary metabolites. Currently, 
natural products isolated from molluscs are particularly 
well represented in the anticancer compounds in clinical 
trials e.g. elisidepsin, a novel marine-derived cyclic peptide 
belonging to the Kahalalide family of compounds currently 
under phase II development with preliminary evidence of 
antitumor activity[6].
   The formation of new blood vessels out of pre-existing 
capillaries or angiogenesis is a sequence of events that 
is of key importance in a broad array of physiologic and 
pathologic processes. In several diseases, excessive 
angiogenesis is a part of the pathology. These diseases 
include cancer (both solid and hematologic tumors[7], 
cardiovascular disease (atherosclerosis)[8], chronic 
inflammation (rheumatoid arthritis, Crohn’s disease), 
diabetes (proliferative diabetic retinopathy)[9], neovascular 
wet age related macular degeneration[10], retinopathy of 
prematurity[11], psoriasis[12] and AIDS complications[13]. These 
diseases may benefit from the therapeutic inhibition of 
angiogenesis. A growing tumor needs an extensive network 
of capillaries to provide nutrients and oxygen to the body 
tissues. In addition, the new intratumoral blood vessels 
provide a way for tumor cells to enter the circulation and 
to metastasize to distant organs. Thus, every organ system 
may involve diseases in which angiogenesis is an important 
component. Several compounds from marine sources 
are under clinical trials and have been shown to possess 
potent angiostatic effect in the pre-clinical phases e.g. 
squalamine[14]. In recent years, many bioactive compounds 
have been isolated from cone snails, soft corals, sponges, 
sea squirts, marine worms, bryozoans, sea slug, sharks and 
other marine organisms and among these, shark cartilage 
have been recognized as an important source of bioactive 
compounds having antiangiogenic potential.  
   As marine organisms from Indian seas are considered 
as potential sources of bioactive molecules, this study was 
undertaken for the first time to explore the antiangiogenic 
properties of the methanolic extracts of various species 
of marine invertebrates from phylum Mollusca using 
in ovo chick chorio-allantoic membrane (CAM) assay. 
The methanolic extracts that showed noticeable in ovo 
antiangiogenic activity were further evaluated for in vivo 
antiangiogenic activity using chemical cautery induced 
corneal neovascularization assay in rats and oxygen induced 
retinopathy in rat pups.   
2. Materials and methods
2.1. Drugs and chemicals
   VEGF, bryostatin 1 and dolastatin 15 were purchased from 
Sigma-Aldrich, USA. Squalamax (natural shark squalamine 
extract) was purchased from Nu Gen, USA. Thalidomide was 
purchased from Natco pharma, Hyderabad. Silver nitrate and 
potassium nitrate were purchased from Qualigens, Mumbai. 
Bevacizumab was obtained from Genentech, USA. All the 
other reagents were of analytical grade and were used 
without further purification. 
   All study protocols were approved by standing Institutional 
Animal Ethics Committee (IAEC) of All India Institute of 
Medical Sciences (AIIMS), New Delhi, India. All animal 
experiments were done in accordance with guidelines of 
Association for Research in Vision and Ophthalmology.
2.2. Collection and identification of marine invertebrates
   Live specimens of twenty two marine invertebrates of 
phylum Mollusca were collected from Cuddalore coastal 
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areas (latitude 11°45ʹ N; longitude 79°45ʹ E) of Tamil Nadu, 
southeast coast of India. The marine samples were brought 
in ice to the laboratory and stored at -20 °C. The samples 
were identified by Dr. M. Arumugam, marine biologist 
at the Centre for advanced study in marine biology, 
Annamalai University, Tamil Nadu. Among the twenty two 
molluscan species, four were identified as cephalopods, 
five were bivalves and thirteen were identified as gastropod 
species. The cephalopods were identified as Sepiella 
inermis (Sepiidae), Sepiella brevimana (Sepiidae), Loligo 
uyii (Loliginidae) and Cistopus indicus (Octopodidae). 
The bivalves were identified as Perna viridis (Mytilidae), 
Meretrix meretrix (Veneridae), Meretrix casta (Meretricinae), 
Crassotrea madrasensis (Ostreidae), Anadara granosa 
(Arcidae). The gastropods were identified as Babylonia 
spiratta (Babylonidae), Rapana rapiformis (Muricidae), Murex 
virgineus var. ponderasa (Muricidae), Turritella acutangula 
(Turritellidae), Cerithidea cingulata (Potamididae), 
Telescopium telescopium (Potmididae), Bursa crumena 
(Bursidae), Conus betulinus (Conidae), Tonna dolium 
(Tonnidae), Hemifusus cochlidium (Melongenidae), Ficus 
ficus (Ficidae), Tudicula spirallis (Turbinellidae) and Conus 
amadis (Conidae). 
2.3. Extraction of marine invertebrates
   The soft bodies of all the marine species were further 
processed prior to their extraction. The ink gland was 
removed from all cephalopods and the outer shells of the 
bivalves and gastropods were cut opened. All the organisms 
were chopped into small pieces, weighed (200 g) and 
macerated with methanol (500 mL) for 7 d, respectively. The 
extracts were filtered and concentrated to dryness using a 
rotary evaporator and the extracts were further stored at 4 °C 
until analysis.  
2.4. Evaluation of antiangiogenic activity of marine 
molluscan species 
2.4.1. Chick CAM assay
   The chick CAM assay was performed as per the procedure 
previously standardized in our laboratory[15]. Briefly, fresh 
fertile white leghorn chick eggs were purchased from 
Kegg Farm (Gurgaon, Haryana, India) and further placed 
in a humidified incubator at (36依2) °C. On the third day 
of incubation, a hole was drilled on the egg shell and 2-3 
mL of albumin was withdrawn aseptically. The hole was 
sealed using sterile parafilm and eggs were re-subjected 
for incubation. And 10 mg/mL stock solution of each extract 
was prepared by dissolving 10 mg extract in 100 µL DMSO 
and 900 µL ovalbumin. On seventh day, a suitable window 
was opened and VEGF (50 ng) in ovalbumin coated coverslips 
of 12 mm diameter (with or without test substance) were 
placed over the CAM. Coverslips coated only with ovalbumin, 
ovalbumin with VEGF, ovalbumin with VEGF and standards 
(thalidomide, squalamine, dolastatin 15 and bryostatin 
1), ovalbumin with VEGF and methanolic extracts (200 µg) 
served as normal, control, positive control and test groups 
respectively (n=8). The windows were further sealed with 
sterile parafilm and reincubated for further period up till 
twelfth day. On Day 12, the blood vessels grown under the 
coverslip area were digitally photographed using a sensitive 
CCD camera directly attached to the computer using graphic 
user interface. The blood vessel areas were analysed using 
the aphelion developer image analysis software (Adcis, 
France). 
2.4.2. Corneal neovascularization assay 
   Corneal neovascularization was induced by chemical 
cauterization as per the procedure previously standardized 
in our laboratory[15]. Briefly, one cornea of each rat 
was cauterized by pressing an applicator stick (with a 
diameter of 1.5 mm) coated with 75% silver nitrate/25% 
potassium nitrate on the centre of the corneas for 5 seconds 
while the animal was deeply anesthetized with sodium 
pentobarbitone. To increase the reproducibility of the 
injuries, the same investigator cauterized all animals. 
Following cauterization, the rats were randomized to 
eliminate potential bias in the degree of injury within 
the different groups. The methanol extracts of Meretrix 
casta, Meretrix meretrix, Telescopium telescopium and 
Bursa crumena were weighed (10 mg), dissolved in 100 µL 
DMSO and final volume was made up with normal saline 
to obtain a concentration of 10 mg/mL (1% w/v). Rats were 
randomly divided into different groups (n=6) viz. sham, 
positive control (bevacizumab 1.25 mg/mL) and methanolic 
extracts (1% w/v) treated. And 20 µL drop of test was applied 
topically to each cauterized cornea three times per day for 5 
d starting from the day of cauterization. The first treatment 
with each medication was started approximately 30 min 
after cauterization. The corneal neovascularization was 
assessed on Day 6 after cauterization whereby the corneas of 
all rats were subjected for photography using CCD camera. 
The photographs were further subjected for quantification 
of corneal neovascularization using the aphelion developer 
image analysis software.
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2.4.3. Oxygen induced retinopathy assay
   Induction of retinopathy in rat pups was carried out as per 
the previously reported procedure[16]. Briefly, Wistar albino 
nursing rats with pups were placed in an incubator with 
80%依2% oxygen starting at postnatal Day 7 (P7) through P12. 
The oxygen levels were measured with an oxygen sensor 
and checked atleast twice daily. On P12, animals were 
returned to room air. Treatment consisted of intraperitoneal 
injection of the test substance, once daily from P12 to P16. 
The methanolic extracts of Meretrix casta, Meretrix meretrix, 
Telescopium telescopium and Bursa crumena were weighed 
(10 mg), dissolved in 100 µL DMSO and final volume was made 
up with normal saline to obtain a concentration of 10 mg/
ml (1% w/v). The rat pups were divided into different group’s 
viz. control (normoxia), control (hyperoxia), positive control 
(bevacizumab 1.25 mg/mL) and test (methanolic extracts 100 
mg/kg) groups respectively. The fundus imaging of all the 
rat pups was carried out using Micron III retinal imaging 
microscope (Phoenix Research Laboratories, USA). The retinal 
images were further subjected for quantification using the 
aphelion developer image analysis software. 
2.5. Statistical analysis
   All the Data presented as mean依SEM. The statistical 
analysis was performed using unpaired student-t test using 
Sigma plot version 11 (Systat, California) and P<0.05 was 
considered as significant. 
3. Results
3.1. CAM Assay 
   The pro-angiogenic growth factor VEGF at the tested 
concentrations of 50 ng induced noticeable degree of 
proliferation of new blood vessels that was observed to 
be significantly (P≤0.001) higher than the normal (without 
VEGF) group. Thalidomide was used as a positive control 
for the study that at a concentration of 10 µg showed 70.08% 
inhibition of VEGF induced neovascularization. A known 
antiangiogenic agent of marine origin i.e. squalamine was 
also used as a standard that exhibited 75.87% inhibition 
of VEGF induced proliferation of new blood vessels at a 
concentration of 6 µg. Anticancer marine isolates viz. 
dolastatin 15 and bryostatin 1 were also used as controls 
whereby both the drugs profoundly inhibited the VEGF 
induced proliferation of new blood vessels though the 
degree of inhibition varied with the two. Dolastatin 15 at a 
concentration of 1 000 ng exhibited 64.44% inhibition whereas 
Bryostatin 1 at the same concentration exhibited relatively 
higher degree of inhibition (75.68%) of the VEGF induced 
angiogenesis . 
   Among the twenty two methanolic extracts of the 
marine invertebrates, four extracts viz. Meretrix meretrix, 
Meretrix casta, Telescopium telescopium and Bursa 
crumena methanolic extracts were observed for noticeable 
antiangiogenic activity at the tested concentration of 200 
µg thereby signifying their anti-VEGF potential (Figure 
1) and were further evaluated for in vivo antiangiogenic 
activity. Among these four methanolic extracts, the Meretrix 
casta extract exhibited noticeably higher antiangiogenic 
activity with an inhibition of 64.63% of the VEGF induced 
neovascularization. The methanolic extracts of Telescopium 
telescopium and Bursa crumena showed comparable effects 
as they were observed for 62.02% and 60.48% inhibition of 
new blood vessels formation while the methanolic extract 
of Meretrix meretrix showed only 47.01% inhibition of 
neovascularization in comparison to the VEGF control group. 
The total area of blood vessels in the coverslip area for all 
the groups was quantified using the image analysis software 
(Table 1). 
Figure 1. Effect of methanolic extracts of marine invertebrate species on the 
chick CAM observed on Day 12 of incubation. Photographs showing blood 
vessels on the CAM for different groups. 
A. Normal. B. Treated with VEGF 50 ng. C. Treated with Thalidomide 10 µg 
along with VEGF 50 ng. D. Treated with Squalamine 6 µg along with VEGF 
50 ng. E. Treated with Dolastatin 1 µg along with VEGF 50 ng. F. Treated 
with Bryostatin 1 µg along with VEGF 50 ng. G. Treated with Meretrix casta 
methanolic extract 200 µg along with VEGF 50 ng. H. Treated with Meretrix 
meretrix methanolic extract 200 µg along with VEGF 50 ng. I. Treated with 
Telescopium telescopium methanolic extract 200 µg along with VEGF 50 ng. J. 
Treated with Bursa crumena methanolic extract 200 µg along with VEGF 50 ng. 
A B C
D E F
G H I J
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Table 1
Representation of vessel area per coverslip in CAM assay.
Group/Extract   
Vessel Area/Coverslip 
(mm×mm) 
Normal  38.916依0.375*
Control (VEGF 50 ng)  91.019依0.184*
Thalidomide 10 µg+VEGF 50 ng  27.233依0.352*
Bryostatin 1 µg+VEGF 50 ng  22.145依0.756*
Dolastatin 1 µg+VEGF 50 ng  32.393依0.611*
Squalamine 6 µg+VEGF 50 ng  21.963依0.460*
Sepiella inermis+VEGF 50 ng 90.539依0.199
Perna viridis+VEGF 50 ng 90.013依0.458
Meretrix meretrix+VEGF 50 ng  48.222依0.961*
Meretrix casta+VEGF 50 ng  32.192依0.428*
Babylonia spiratta+VEGF 50 ng  57.569依0.485*
Loligo uyii+VEGF 50 ng 79.845依0.703
Crassotrea madrasensis+VEGF 50 ng 90.221依0.458
Cistopus indicus+VEGF 50 ng 81.754依0.589
Sepiella brevimana+VEGF 50 ng 90.959依0.444
Anadara granosa+VEGF 50 ng 90.343依0.366
Rapana rapiformis+VEGF 50 ng 90.305依0.321
Murex virgineus var. ponderasa+VEGF 50 ng 89.320依0.750
Turetella acutangula+VEGF 50 ng 90.529依0.400
Cerithidea cingulatta+VEGF 50 ng 90.770依0.401
Telescopium telescopium+VEGF 50 ng  34.564依0.486*
Bursa crumena+VEGF 50 ng  35.963依0.972*
Conus betulinus+VEGF 50 ng 77.096依0.440
Tonna dolium+VEGF 50 ng 89.044依0.969
Hemifusus cochlidium+VEGF 50 ng 90.282依0.278
Ficus ficus+VEGF 50 ng  55.884依0.527*
Tudicula spirallis+VEGF 50 ng  90.147依0.480
Conus amadis+VEGF 50 ng  90.614依0.332
10% DMSO in ovalbumin+VEGF 50ng  90.806依0.225
Data presented as mean依SEM (n=8). *P≤0.001 vs Control Group. 
3.2. Cautery induced corneal neovascularization
   There was no corneal neovascularization observed in the 
normal (uncauterized) corneas. Among all the four tested 
extracts, the methanolic extract of Telescopium telescopium 
exhibited most noticeable inhibition (42.58%) of the chemical 
cautery induced corneal neovascularization in rats (Figure 2) 
in comparison to the sham treated group that was observed 
for considerable neovascularization in the cauterized corneas 
of rat eyes. Comparatively, bevacizumab (positive control) 
showed significant (P≤0.001) inhibition (70.05%) of the cautery 
induced corneal neovascularization. The methanolic extract 
of Bursa crumena showed 26.74% inhibition of the corneal 
neovascularization. The methanolic extracts of Meretrix 
species viz. Meretrix casta and Meretrix meretrix were found 
to offer only 19.7% and 12.14% inhibition respectively in this 
model (Table 2). 
Figure 2. Effect of methanolic extracts of marine invertebrate species in cautery 
induced corneal neovascularization in rats. Photographs showing rat corneas for 
different groups. 
A. Cauterized cornea. B. Normal cornea. C. Sham treated cornea. D. Bevacizumab 
1.25 mg/mL treated cornea. E. Telescopium telescopium methanolic extract (1% w/
v) treated cornea. E. Bursa crumena methanolic extract (1% w/v)  treated cornea. 
E. Meretrix casta methanolic extract (1% w/v) treated cornea. E. Meretrix meretrix 
methanolic extract (1% w/v) treated cornea.
A
E F G H
B C D
Table 2
Vessel area in the cauterized corneas of different groups.
Group/Extract  Area of corneal blood vessels (mm×mm) 
Sham 17.05依0.499
Bevacizumab    5.11依0.283*
Meretrix meretrix 14.98依0.464
Meretrix casta  13.69依0.302*
Telescopium telescopium    9.79依0.345*
Bursa crumena  12.49依1.168* 
10% DMSO in normal saline 17.55依0.316
Data presented as mean依SEM (n=6). *P≤0.05 vs Sham treatment.
3.3. Oxygen induced retinopathy assay
   The hyperoxia (80% oxygen) treated control group rat pups 
showed significant (P≤0.001) retinal neovascularization in 
comparison to the normoxia treated rat pups which were 
kept at ambient air (21% oxygen). The positive control 
bevacizumab exhibited significant (P≤0.001) inhibition of 
the oxygen induced retinal neovascularization in rat pups 
in comparison to the hyperoxia group. Among all the four 
tested methanolic extracts of marine invertebrate’s viz. 
Meretrix meretrix, Meretrix casta, Telescopium telescopium 
and Bursa crumena, the extract of Telescopium telescopium 
exhibited most noticeable inhibition (31.31%) of the oxygen 
induced retinal neovascularization in rat pups (Figure 3) in 
comparison to the hyperoxia group whereas the remaining 
extracts of Bursa crumena, Meretrix casta and Meretrix 
meretrix were observed for only 15.53%, 14.78% and 8.64% 
inhibition of the oxygen induced retinal neovascularization 
(Table 3). 
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Table 3
Quatification of oxygen induced retinal neovascularization.
Group/Extract  Area of corneal blood vessels (mm×mm) 
Normoxia   4.13依0.16*
Control (Hyperoxia) 11.02依0.25
Bevacizumab   5.19依0.72*
Meretrix meretrix  10.07依0.17*
Meretrix casta   9.39依0.13*
Telescopium telescopium   7.56依0.08*
Bursa crumena    9.31依0.11* 
10% DMSO in normal saline 10.98依0.07
Data presented as mean依SEM (n=6). *P≤0.001 vs Control Group. 
4. Discussion
   The quest of antiangiogenic compounds for the treatment 
of neovascular diseases has yielded an array of extracts of 
marine species particularly the invertebrates that bear potent 
angiostatic effects e.g. methanolic extract of the feather star, 
Lamprometra palmata palmate, whole body extract of marine 
gastropod Euchelus asper, etc[17,18]. These extracts of marine 
invertebrates are sources of novel secondary metabolites 
of unprecedented molecular structures and activities. 
The phylum Mollusca represents a majorly unexplored 
domain in the marine ecosystem as there are up to 150 000 
molluscan species and contrary to their vast numbers and 
relative accessibility, not many of these species have been 
investigated for their pharmacological potential. Therefore, 
the present study was designed to evaluate the antiangiogenic 
potential of this majorly unexplored class of marine species, 
particularly phylum Mollusca that has been a potential 
source of several anticancer compounds such as dolastatins, 
Aplyronine A, Kahalalide F and Jorunnamycins A-C[19]. 
   Angiogenesis, the physiological process involving the 
growth of new blood vessels from pre-existing ones, is 
essential for organ growth and repair. Angiogenesis involves 
a series of co-ordinated events such as endothelial cell 
proliferation and migration, capillary tube formation, 
extracellular matrix degeneration and remodeling[20]. The 
process of angiogenesis is tightly regulated by the balance 
between angiogenesis stimulators and inhibitors. However, 
the imbalance in angiogenesis contributes to numerous 
pathologies that may play a pivotal role in tumor growth and 
metastasis. In several ocular neovascular diseases such as 
age related macular degeneration, diabetic retinopathy and 
retinopathy of prematurity, excessive angiogenesis occurs 
when diseased cells produce abnormally large amounts of 
angiogenesis factors e.g. VEGF, overwhelming the effects 
of natural angiogenesis inhibitors such as angiostatin. 
Antiangiogenic therapies, which are aimed at suppressing 
new blood vessel growth, are being developed for treating 
these chronic ocular diseases that are the leading causes of 
blindness in the infants, adults of working age and the elderly 
in the developed world[21]. Today, over 20 angiogenic growth 
factors and over 300 antiangiogenic molecules from natural 
and synthetic sources, targeting different signaling pathways 
are being tested for their anticancer properties at preclinical 
and clinical stages and among these the anti-VEGF therapies 
are being looked forward for the treatment of pathological 
ocular neovascularization[22,23].   
   The chick CAM assay is a preliminary in ovo assay 
technique and since the CAM has a very dense capillary 
network, it is commonly employed for evaluating 
neovascularization and its inhibition in response to different 
angiogenic stimulators[24]. An important growth factor in 
angiogenesis is VEGF that has been applied on the CAM from 
Day 7 to Day 12 for the induction of neovascularization. 
In the CAM of embryos of this age, VEGF induces vascular 
growth in the region of the capillaries and also in the pre- 
and post-capillary vessels by sprouting angiogenesis. VEGF 
stimulates the cells to produce matrix metalloproteinases, 
which degrade the basement membrane and surrounding 
extracellular matrix. As a result, endothelial cells proliferate 
and migrate towards the interstitium, where they start 
sprouting. Subsequently, the cells proliferate and migrate 
towards the newly formed sprouts and mature by forming 
single cell layer around the sprout[25]. Antiangiogenic drugs 
prevent the binding of VEGF with its receptors on the surface 
of the endothelial cells. Owing to its central role in promoting 
tumor growth, VEGF has now become a key therapeutic target 
and its functions can be blocked at different levels of the 
signaling pathways. Therefore, in this study VEGF was used 
as an angiogenic stimulator in CAM assay at a concentration 
of 50 ng for the stimulation of controlled angiogenesis within 
the coverslip area of 113.14 mm2. Similar concentration was 
also used for the induction of neovascularization in the chick 
embryo’s by Lingaraju and coworkers[26]. 
   Thalidomide was used as a positive control for the CAM 
assay as its an known inhibitor of angiogenesis[27]. The 
effect of thalidomide on growing vasculature in chick CAM 
without any inducer of angiogenesis has been demonstrated 
previously whereby it has been reported that the implantation 
Figure 3. Effect of methanolic extract of Telescopium telescopium in oxygen 
induced retinal neovascularization in rat pups. Photographs showing rat 
fundus for different groups. 
A. Normoxia group. B. Hyperoxia group. C. Telescopium telescopium 
methanolic extract (100 mg/kg) treated group. 
A B C
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of 0.5% CMC pellets containing thalidomide did not exhibited 
any noticeable antiangiogenic effect in the embryonic 
vasculature[28]. However, further studies reported that 100 
µg/mL thalidomide disc noticeably blocked nitric-oxide 
mediated angiogenesis in an ex-ovo chick CAM assay[29]. 
In contrast, the present study directly evaluated the effect 
of thalidomide on the VEGF induced angiogenesis in the 
chick chorioallantoic membrane assay for the first time. 
Thalidomide at a concentration of 10 µg was observed to 
perturb the embryonic vasculature that was induced by 
the action VEGF. Squalamine, an aminosterol antibiotic 
from the liver of the dogfish shark, Squalus acanthus, is a 
proven antiangiogenic compound of marine origin that is 
undergoing clinical trials for the treatment of age related 
macular degeneration. Therefore, it was included in the 
present study for an effective correlation of newer extracts. 
Squalamine extract at a concentration of 6 µg was observed 
for noticeable inhibition of the embryonic vasculature 
induced on the CAM by VEGF. Two anticancer marine isolates 
viz. dolastatin 15 and bryostatin 1 were also used as controls 
in the CAM assay. Dolastatins are unique natural peptides 
derived from the marine mollusca Dolabella auricularia and 
dolastatin 15 is a small peptide from the class of dolastatins 
that have been identified as an inhibitor of microtubule 
assembly that induces mitotic arrest and apoptosis of human 
multiple myeloma cells[30]. The results showed that dolastatin 
15 produced noticeable inhibition (64.44%) of VEGF induced 
angiogenesis in the CAM assay at a concentration of 1 µg. 
Bryostatin 1 is a macrolactone isolated from the marine 
bryozoan Bugula neritina and is a protein kinase C activator 
that has been reported to inhibit leukemic growth in vitro via 
cell cycle arrest at G2 (as well as G1)[31]. The results showed 
that bryostatin showed a maximum of 75.68% inhibition at 
a concentration of 1 µg which was comparatively higher 
to the inhibition observed with dolastatin 15 at the same 
concentration indicating higher potency of bryostatin 1.   
   Among all the twenty two marine invertebrate extracts 
evaluated for their antiangiogenic potential, the methanolic 
extracts of Meretrix meretrix, Meretrix casta, Telescopium 
telescopium and Bursa crumena exhibited significant (P≤0.001) 
anti-angiogenic activity in comparison to the VEGF control 
group. However, among all the four extracts, an appreciable 
antiangiogenic activity was observed with the methanolic 
extract of Meretrix casta followed by Telescopium telescopium, 
Bursa crumena and Meretrix meretrix extracts. Interestingly, 
the activity of all the four methanolic extracts was found 
have dose dependent positive correlation in antiangiogenic 
activity. These obervations make them worthy of subjecting 
for further in vivo studies.  
  Corneal neovascularization is a consequence of infection, 
inflammation, trauma and toxic or degenerative corneal 
disorders. Corneal NV may cause oedema, scar formation or 
lipid deposition leading to significant visual impairment[32]. 
Corneal neovascularization appears to be controlled by two 
opposing mechanisms: angiogenic stimulators such as VEGF 
and angiogenic inhibitors such as angiostatin. Under normal 
conditions, the balance is toward the endogenous angiogenic 
inhibitors, keeping the cornea avascular. An insult to 
the cornea, may enhance the production of angiogenic 
stimulators, disturing the balance and resulting in capillary 
endothelial cell proliferation and neovascularization. In 
the present study, 75% silver nitrate/25% potassium nitrate 
applicator sticks were used for the purpose of cauterization 
of the rat corneas. As the silver nitrate contacts with water 
(in the blood) the compound goes into solution forming nitric 
acid which is subsequently responsible for the cautery effect. 
The combination of silver nitrate with potassium nitrate 
toughens silver nitrate so that it can be applied quickly and 
conveniently to the precise area to be cauterized without 
spread to the adjacent healthy tissues. 
   VEGF is a potent and highly selective mitogen for vascular 
endothelial cells and substantial evidences indicate 
that VEGF and its receptors play an important role in the 
pathophysiology of corneal NV and are upregulated in corneal 
angiogenesis thereby playing a key role in the pathogenesis 
of corneal neovessels[33]. Pharmacological treatment of 
corneal neovascularization using angiogenic inhibitors has 
evolved a new way to manage corneal neovascularization. 
Lately, the success of monoclonal antibodies against 
VEGF such as bevacizumab in the treatment of retinal and 
choriodal neovascularization has encouraged the use of these 
antibodies to treat corneal neovascularization and this is 
evident from the pre-clinical studies that reported topically 
administered bevacizumab significantly reduces corneal NV 
in rats[34]. Bevacizumab was used as a positive control for the 
present study that showed significant inhibition of the cautery 
induced corneal neovascularization in rats in comparison to 
the sham treated group. 
   The methanolic extracts of Telescopium telescopium, 
Bursa crumena, Meretrix meretrix and Meretrix casta that 
exhibited noticeable anti-angiogenic activity in the CAM 
assay were further evaluated for their in vivo antiangiogenic 
potential using silver nitrate cautery induced corneal 
neovascularization assay in rats. For the topical application 
in the eye, the stock solution (10 mg/mL) of the extracts was 
prepared by dissolving 10 mg of each extract in 10% DMSO 
and volume made up with normal saline. The osmolarity of 
the four solutions of methanolic extracts of Meretrix meretrix, 
Meretrix casta, Telescopium telescopium and Bursa crumena 
were measured using osmometer (µ OsmetteTM 5004, 
Precision Systems, USA) and was found to be 410, 416, 413 and 
405 mOsm, respectively.
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   The methanolic extract of Telescopium telescopium 
exhibited most noticeable inhibition of the chemical cautery 
induced corneal neovascularization in rats which was 
highest among all the tested extracts but 1.5 folds lower 
than the positive control i.e. bevacizumab. The significant 
anti-angiogenic activity observed for the extract may be 
due to the anti-VEGF activity as observed for the extract in 
the CAM assay. However, as the biological system serves as 
an epicentre for several growth mediators of angiogenesis 
other than VEGF, therefore a possibility of inhibition of 
other mediators cannot be ruled out, thus emphasizing for 
further insght into the mechanisms of actions involved for 
the extract. The methanol extracts of other three molluscan 
species viz. Bursa crumena, Meretrix casta and Meretrix 
meretrix showed only slight antiangiogenic activity as they 
were observed for only 26.74%, 19.7% and 12.14% inhibition of 
the cautery induced corneal neovascularization in rats. In this 
study, the protection offered by the extracts were found to be 
significant but relatively low as compared to bevacizumab. 
This might be due to the presence of lower concentrations of 
active principle in the prepared extracts. Furthermore, due 
to non-solubility of the entrire extract, this study used 10% 
DMSO for solubilizing the extract in saline to enable its topical 
instillation. DMSO at 10% can cause ocular surface irritation 
and cause lacrimation which can clear precorneal tear drug 
concentraiton in a faster rate. Although angiogenesis found 
in the vehicle treted control was undifferentiatable from the 
sham treated animal, effect of DMSO interfering the marine 
isolates for their protective action can not be ruled out. 
   The functional relationship between inflammation and 
tumors is not new as the role and involvement of angiogenesis 
for the growth of tumors has been widely recognized and 
antiangiogenic drugs with inherent anti-inflammatory 
potential seem likely to be biologically plausible for the 
treatment of inflammation dependent pathological ocular 
angiogenesis primarily observed in ocular tumors and 
corneal neovascularization[35]. Inflammation-dependent 
angiogenesis seems to be a central force in tumor growth[36], 
a concept supported by the observation that the use of 
classical anti-inflammatory drugs, such as non steroidal anti 
inflammatory drugs (NSAIDs), leads to the inhibition of ocular 
neovascularization e.g. nepafenac[37]. The mechanisms of 
inflammatory angiogenesis provide new approaches to cure 
or prevent angiogenesis occurring in cases of ocular tumors 
and pathological corneal neovascularization. In the present 
study, the methanolic extract of Telescopium telescopium, 
that exhibited noticeable inhibition of the chemical cautery 
induced corneal neovascularization in the rats, signify its 
potential for further development as an novel antiangiogenic 
therapy for the treatment of inflammation dependent 
pathological ocular angiogenesis.  
   In the retina, hypoxia may occur as a result of vascular 
disruption caused by various pathologies, such as 
hyperglycaemia in diabetes, thrombosis in vein occlusions 
or developmental delays in retinopathy of prematurity. 
Normally, hypoxia is a key driving force inducing a 
vascular response, whereby insufficiently perfused tissue 
is revascularized by the sprouting of new capillaries 
from pre-existing vessels. In theory, hypoxia in the eye 
should therefore result in compensatory revascularization 
to replenish vessel starved areas. However, for reasons 
not well understood, the revascularization is sometimes 
not successful, leading to abnormal vessels so called 
‘neovascularization’–instead of healthy, new capillaries. This 
is a major vision-threatening complication in many ischemic 
retinopathies because the abnormal blood vessels leak, cause 
edema and exert tractional forces, causing in worst case 
scenarios retinal detachment. 
   The rat model of oxygen-induced retinopathy has been 
widely used as an animal model of the human form of this 
disease, retinopathy of prematurity. The oxygen-induced 
retinopathy model in rat pups provides an excellent model 
system for evaluating abnormal angiogenesis in the retina that 
includes reproducible proliferative retinal neovascularization. 
In contrast with other animal models that have been used to 
study the pathophysiology of this disease, the neonatal rats 
offer the advantage of a highly immature retina at birth that 
is comparable to that of a 24-26 week old human embryo. As 
in humans, exposure of the rat pups to postnatal hyperoxia 
from P7 to P12 causes severe vasoconstriction and vaso-
obliteration, followed by an abnormal proliferation of retinal 
vessels upon return to room air due to the oxidative stress[38].
   Among all the four extracts of molluscan species, the 
methanolic extract of Telescopium telescopium exhibited 
most noticeable inhibition of the oxygen induced retinal 
neovascularization in rat pups. The significant (P≤0.001) 
antiangiogenic activity observed for the extract may be due 
to its anti-VEGF potential as VEGF has been implicated as one 
of the key underlying factors in the pathogenesis of retinal 
neovascularization[39]. The methanolic extracts of other 
three molluscan species viz. Bursa crumena, Meretrix casta 
and Meretrix meretrix exhibited only slight antiangiogenic 
activity as they were observed for 15.53%, 14.78% and 8.64% 
inhibition of the oxygen induced retinal neovascularization in 
rat pups. In this study, the protections offered by the extracts 
were found to be significant but the inhibitory percentages 
were lower that might be due to the presence of lower 
concentrations of active principles in the prepared extracts.
   This is the first report on the antiangiogenic potential 
of twenty two marine invertebrate species from phylum 
mollusca from the Indian oceans. The present study revealed 
in ovo antiangiogenic potential of Meretrix casta, Telescopium 
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telescopium, Bursa crumena and Meretrix meretrix extracts 
and further evaluated them for in vivo antiangiogenic 
potential. The noticeable inhibition of the cautery induced 
corneal neovascularization and oxygen induced retinal 
neovascularization evinced by the methanolic extract of 
Telescopium telescopium merits further investigation for ocular 
neovascular diseases. Detailed phytochemical examination of 
the methanolic extract of Telescopium telescopium to isolate 
the putative active principles responsible for the observed 
activity is in progress in our laboratory.  
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Comments 
Background
   Angiogenesis is a complex process and dys-regulation 
of which leads to various pathologies including ocular 
angiogenesis leading to vision loss. The currently available 
state-of-the art anti-angiogenic therapies targets the VEGF 
pathway which is a key player in angiogenesis. However, 
the benefits of current anti-angiogenic agnets are verymuch 
limited with serious side effects. Therefore, there is a need 
to explore newer anti-angiogenit agents from marine source 
because of its special mode of action. 
  
Research frontiers
   The present study investigated the effect of methanolic 
extract of marine invertebrates from Indian Ocean on 
experimentally induced angiogenesis both ex vivo and in 
vivo and assessed its anti-angiogenic property for its future 
development as a potential candidate for ocular angiogenesis
Related reports
   Vascular endothelial growth factor (VEGF) plays a major role 
in angiogenesis. The secondary metabolites obtained from 
marine organisms gaining momentum in anti-tumor drug 
discovery process in the recent past and they are reported to 
have anti-angiogenic properties.
Innovations and breakthroughs
   Marine invertebrates constitute one of the major groups 
of marine organisms and many potential anti-angiogenic 
compounds have isolated from them for human use. In 
the present study, authors have demonstrated the anti-
angiogenic activity of methanolic extracts of phylum mollusca 
in CAM assay, corneal neovascularization assay and oxygen 
induced retinopathy assay 
  
Applications
   Drugs derived from marine mollusks are reported to be very 
safe for human use. The present study support and suggest 
the use of this marine organism as a resource to isolate 
compounds against ocular angiogenesis. 
Peer review
   This is a valuable research work in which authors have 
demonstrated the anti-angiogenic property of marine 
invertebrates in ovo angiogenesis (CAM assay) model and 
ocular angiogenesis experimental model in rats. The activity 
was accessed based on the extent of inhibiting new vessel 
formation induced by VEGF, chemical injury and hyperoxia. 
Out of 22 extracts studied, Telescopium telescopium was found 
to be a potential candidate for further development for ocular 
angiogenesis.
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